Kala Pharmaceuticals's market cap is currently ―. The company's EPS TTM is $-17.94; its P/E ratio is -0.38; Kala Pharmaceuticals is scheduled to report earnings on May 9, 2024, and the estimated EPS forecast is $-2.89. See an overview of income statement, balance sheet, and cash flow financials.

	Dec 23	Sep 23	Jun 23	Mar 23	Dec 22
Income Statement	-
Total Revenue	-	-	-	-	-
Gross Profit	-	-	-	-	-
EBIT	$ -6.60M	$ -10.73M	$ -8.28M	$ -12.98M	$ -11.62M
EBITDA	$ -6.22M	$ -10.35M	$ -7.90M	$ -12.57M	$ -11.24M
Net Income Common Stockholders	$ -8.63M	$ -8.70M	$ -10.41M	$ -14.46M	$ -12.84M
Balance Sheet	-
Cash, Cash Equivalents and Short-Term Investments	$ 50.90M	$ 56.06M	$ 59.18M	$ 63.64M	$ 70.50M
Total Assets	$ 55.95M	$ 61.12M	$ 66.50M	$ 71.72M	$ 86.82M
Total Debt	$ 36.32M	$ 36.08M	$ 33.57M	$ 33.27M	$ 42.95M
Net Debt	$ -14.57M	$ -19.98M	$ -25.61M	$ -30.37M	$ -27.55M
Total Liabilities	$ 48.45M	$ 49.90M	$ 49.01M	$ 48.77M	$ 67.85M
Stockholders Equity	$ 7.50M	$ 11.22M	$ 17.49M	$ 23.46M	$ 18.97M
Cash Flow	-
Free Cash Flow	$ -7.70M	$ -2.95M	$ -7.55M	$ -9.68M	$ -13.66M
Operating Cash Flow	$ -7.70M	$ -2.95M	$ -7.59M	$ -9.68M	$ -13.73M
Investing Cash Flow	$ -7.00K	$ 9.72M	$ -10.03M	$ -108.00K	$ 51.00K
Financing Cash Flow	$ 2.54M	$ 40.00K	$ 3.07M	$ 2.86M	$ 31.79M

Currency in USD

Kala Pharmaceuticals Earnings and Revenue History

Income Statement >

Kala Pharmaceuticals Debt to Assets

Balance Sheet >

Kala Pharmaceuticals Cash Flow

Cash Flow >

Kala Pharmaceuticals Forecast EPS vs Actual EPS

Earnings >

Get More with TipRanks Premium

What's Included in PREMIUM?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing